InvestSMART

MGC Pharmaceuticals Ltd (ASX: MXC) - Announcements

Current share price for MXC : $0.420 0.01 (2.44%)+

ASX company news and announcements for MGC Pharmaceuticals Ltd (MXC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All MGC Pharmaceuticals Ltd (MXC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than MGC Pharmaceuticals Ltd (MXC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for MGC Pharmaceuticals Ltd (MXC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 MGC Pharma Crosses 2,000 Prescription Milestone 9 Jan 2020 9:41AM $0.033 $0.420 risen by 1,172.73%
$18 Launch of New Product Line in Aus & NZ - Mercury Pharma 7 Jan 2020 10:01AM $0.032 $0.420 risen by 1,212.50%
$18 Change of Director's Interest Notice - Appendix 3Y x 2 2 Jan 2020 8:25AM $0.032 $0.420 risen by 1,212.50%
$18 Corporate Governance Plan 30 Dec 2019 10:45AM $0.032 $0.420 risen by 1,212.50%
$18 Issue of Securities - Appendix 3B and Cleansing Notice 23 Dec 2019 3:38PM $0.031 $0.420 risen by 1,254.84%
$18 First Shipment of CogniCann en route to Australia 19 Dec 2019 9:52AM $0.031 $0.420 risen by 1,254.84%
$18 MGC Pharma Removal from BNY Mellon's Restricted List 18 Dec 2019 12:23PM $0.031 $0.420 risen by 1,254.84%
$18 Prescriptions Grow Above 1,800 & First Ireland Prescriptions 17 Dec 2019 9:52AM $0.030 $0.420 risen by 1,300%
$18 Approval Received for Distribution of CannEpil into Ireland 3 Dec 2019 9:44AM $0.033 $0.420 risen by 1,172.73%
$18 Results of Annual General Meeting 29 Nov 2019 7:39PM $0.034 $0.420 risen by 1,135.29%
$18 MGC Pharma AGM Webinar 27 Nov 2019 12:46PM $0.034 $0.420 risen by 1,135.29%
$18 Growth in Prescriptions Issued Continues During November 26 Nov 2019 9:53AM $0.034 $0.420 risen by 1,135.29%
$18 Binding Term Sheet to Immediately Expand into Latin America 22 Nov 2019 9:47AM $0.034 $0.420 risen by 1,135.29%
$18 Trading Halt 20 Nov 2019 12:31PM $0.034 $0.420 risen by 1,135.29%
$18 Pause in Trade 20 Nov 2019 12:14PM $0.034 $0.420 risen by 1,135.29%
$18 UK and Australia Roadshow Presentation 14 Nov 2019 6:11PM $0.036 $0.420 risen by 1,066.67%
$18 Company Update- Government Grant Received, LSE Dual Listing 12 Nov 2019 1:32PM $0.035 $0.420 risen by 1,100%
$18 September Quarterly Activity and Cashflow Report 31 Oct 2019 1:50PM $0.034 $0.420 risen by 1,135.29%
$18 MGC Reaches 1,000 Prescription Milestone Ahead of Schedule 31 Oct 2019 9:38AM $0.034 $0.420 risen by 1,135.29%
$18 Notice of Annual General Meeting/Proxy Form 29 Oct 2019 12:29PM $0.034 $0.420 risen by 1,135.29%
$18 800 Prescription Milestone Passed for MGC Pharma Products 24 Oct 2019 9:59AM $0.033 $0.420 risen by 1,172.73%
$18 Annual Report 2019 18 Oct 2019 8:00PM $0.036 $0.420 risen by 1,066.67%
$18 Appendix 4G and Corporate Governance Statement 18 Oct 2019 2:23PM $0.035 $0.420 risen by 1,100%
$18 600 Prescription Milestone Passed for MGC Pharma Products 16 Oct 2019 9:47AM $0.034 $0.420 risen by 1,135.29%
$18 MGC Pharma Passes 400 Prescription Milestone in September 3 Oct 2019 9:28AM $0.039 $0.420 risen by 976.92%

501 - 525 of 818 results

Page 21 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.